Journal article

Alectinib as first-line therapy for ALK-rearranged NSCLC: A no-brainer?

AA Thai, BJ Solomon

Annals of Oncology | OXFORD UNIV PRESS | Published : 2018

DOI: 10.1093/annonc/mdy415

University of Melbourne Researchers

Grants

Citation metrics

1Scopus
4Web of Science
2Dimensions

Keywords

Impact
32 Biomedical and Clinical Sciences
Open-Label
Life Sciences & Biomedicine
Patterns
Chemotherapy
Oncology
Science & Technology
3202 Clinical Sciences
Metastases
Cell Lung-Cancer
3211 Oncology and Carcinogenesis